OTHER · Unmapped registry intervention
AD Risk factors balance
Find medicine records ·
Find other trials using this name
Clinical trial
HAPPCAP-AD (Human-APPlication Combined Approach for Prevention of Alzheimer's Disease)
NCT05256121
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedHAPPCAP-AD (Human-APPlication Combined Approach for Prevention of Alzheimer's Disease)
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Alzheimer Diseaseverified · MONDO: Alzheimer disease
Interventions
Sponsors & collaborators
Sheba Medical Centerlead sponsor
Maccabi Healthcare Services, Israelcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05256121 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.